ZK International Group (ZKIN)announced that the bid price deficiency concern raised by Nasdaq has been resolved. The company has received ...
Karyopharm Therapeutics (NASDAQ:KPTI) will implement a 1-for-15 reverse stock split of the issued shares of its common stock on February 25, 2025. The split is intended to increase the per-share ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results